Drugs / Survivin peptide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01543464 | May 2012 → Sep 2016 | melanoma | Inge Marie Svane | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Survivin peptide | “Vaccine: 250 microgram IDO5 peptide + 250 microgram Survivin peptide + 500 microL Montanide every 2nd week” NCT01543464 ↗ |
| Modality | Peptide | “Survivin peptide” NCT01543464 ↗ |